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Fluorescence resonance energy transferDaptomycin is a lipopeptide antibiotic that kills Gram-positive bacteria by depolarizing their cell membranes.
This antibacterial action of daptomycin is correlated with the formation of membrane-associated oligomers.
We here examine the number of subunits contained in one oligomer using ﬂuorescence resonance energy
transfer (FRET). The results suggest that the oligomer contains approximately 6 to 7 subunits, or possibly
twice this number if it spans both membrane monolayers.
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The lipopeptide daptomycin is an important reserve antibiotic for
the treatment of infections by otherwise resistant strains of Gram-
positive bacteria such as Staphylococcus aureus and Enterococcus
faecalis [1–3]. Its bactericidal effect involves membrane depolariza-
tion due to permeabilization for potassium ions [4].
Daptomycin has recently been shown to form oligomers on bacte-
rial membranes and on liposome membranes containing phosphati-
dylglycerol [5,6]. Oligomerization is dependent on calcium. The
requirements of oligomerization for both calcium and phosphatidyl-
glycerol mirror those of bactericidal action [7], which suggests that
the oligomer forms the functional membrane lesion, as is the case
with many other membrane-permeabilizing peptides and proteins.
At high concentrations and in the presence of calcium, daptomycin
also undergoes oligomerization in solution. Such oligomers have been
structurally characterized by NMR and by density gradient centrifuga-
tion, and they reportedly consist of 14–16 subunits [8]. On the other
hand, the action of daptomycin has also been compared to that of cation-
ic antimicrobial peptides, many of which do not form discrete oligomers
but rather follow the carpet model of membrane destabilization [9].
In the current study, we therefore set out to determine whether the
membrane-associated oligomer has a deﬁned subunit stoichiometry.
Daptomycin contains several non-standard amino acid residues.
One of these, kynurenine, exhibits an experimentally useful intrinsic
ﬂuorescence that responds with a signiﬁcant gain in quantum yield to.
l rights reserved.membrane interaction [10]. Another one, ornithine, carries themolecu-
le's single free amino group. Derivatization of this ornithine residue can
be used to prepare ﬂuorescent derivatives such as NBD-daptomycin,
which retains antibacterial activity and forms hybrid oligomers with
unlabeled daptomycin [5]. In NBD-daptomycin, kynurenine ﬂuores-
cence is entirely suppressed due to ﬂuorescence resonance energy
transfer (FRET) fromkynurenine toNBD.Moreover, inmixed oligomers,
FRET also occurs between unlabeled daptomycin and NBD-daptomycin.
The experimental approach used here to determine the subunit stoichi-
ometry of the membrane-bound oligomer is based on the latter effect.
The results suggest that the membrane-associated oligomer is smaller
and structurally different from the oligomer observed in solution.
2. Materials and methods
2.1. Materials
Large unilamellar liposomes (LUV)were prepared from an equimolar
mixture of dimyristoyl-phosphatidylcholine (DMPC) and dimyristoyl-
phosphatidylglycerol (DMPG)by extrusion throughpolycarbonatemem-
branes as described [5]. NBD-daptomycin was obtained by reaction of
daptomycin with nitrobenzoxadiazole-chloride (NBD-chloride, Fluka)
and puriﬁcation by HPLC also as described before [5]. Unlabeled dapto-
mycin was supplied by Cubist Inc (Lexington, MA). Other reagents were
of analytical grade and were obtained from Bioshop (Burlington, ON).
2.2. Fluorescence measurements
Samples contained sample buffer (HEPES 20 mM, 150 mM NaCl,
pH 7.4), LUV (250 μM total lipid), calcium chloride (6 mM), and either
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various proportions and total concentrations. Steady state ﬂuores-
cence emission spectra were obtained on a PTI QuantaMaster 4
instrument. For daptomycin and NBD-daptomycin, the excitation
wavelength was 365 nm, and emission was recorded between 400
and 600 nm. For perylene-daptomycin, the excitation wavelength
was 430 nm, and emission was recorded from 440 nm to 600 nm.
Excitation and emission slit widths were adjusted to keep the maxi-
mal emission recorded below 106 counts/s; this latter value was de-
termined to be within the linear range of the instrument's response.
2.3. Determination of the corrected relative kynurenine ﬂuorescence of
daptomycin in mixed oligomer samples
The purpose is to measure the kynurenine ﬂuorescence of unla-
beled daptomycin molecules within oligomers that have formed
from mixtures of daptomycin with NBD-daptomycin, relative to the
ﬂuorescence of the same number of daptomycin molecules within
oligomers formed without NBD-daptomycin, and corrected for
FRET between pure daptomycin oligomers and NBD-daptomycin-
containing oligomers.
Mixtures of daptomycin and NBD-daptomycin, in various propor-
tions as indicated in the Results section, were prepared and added at a
combined ﬁnal concentration of 10 μM to liposomes and calcium and
incubated for 180 s to induce oligomerization before measuring the
kynurenine emission.
To correct for FRET between (as opposed to within) oligomers,
4 μM unlabeled daptomycin was then added to the same sample
and allowed to oligomerize for 180 s, and the kynurenine ﬂuores-
cence was read again. The rationale for this calibration procedure is
explained in the Results section. The relative kynurenine ﬂuorescence
was calculated using the following equation:
Fr ¼
d2
d1
I1−I0
I2
V2
V1
−I1
0
@
1
A ð1Þ
In Eq. (1), Fr is the relative kynurenine ﬂuorescence, and d1 and d2
are the molar amounts of unlabeled daptomycin added in the ﬁrst
and second steps, respectively. I0, I1 and I2 are the emission intensities
at 445 nm of a liposome blank, and of the oligomer sample after the
ﬁrst and second addition of daptomycin, respectively. V1 and V2 are
the sample volumes before and after that addition, respectively; the
term V2/V1 corrects for the dilution caused by the second addition of
daptomycin, which amounted to 4% of the sample volume.
2.4. Numerical simulation of hetero-oligomer formation
The simulation shown in Fig. 5 was implemented as a Python
program. The code of the program, with explanations, is contained
in the supplementary ﬁle to this manuscript.
3. Results
3.1. Rationale of the experimental approach to the determination of
oligomer subunit stoichiometry
The experimental approach used in this study is based on ﬂuores-
cence resonance energy transfer (FRET) between the kynurenine in
unlabeled daptomycin and NBD-daptomycin in hybrid oligomers.
FRET involves the kynurenine residue in unlabeled daptomycin as
the donor, and the NBD moiety of NBD-daptomycin as the acceptor.
We made the following assumptions:
1. All daptomycin oligomers have the same number of subunits, n.
2. Conversion of monomeric daptomycin to oligomers is quantitative
on the time scale of the experiment.3. When native daptomycin and NBD-daptomycin are mixed before
application to membranes, they will form oligomers randomly,
without any positive or negative mutual discrimination.
4. In hybrid oligomers, the kynurenine ﬂuorescence of all unlabeled
daptomycin molecules is completely quenched by FRET. Therefore,
any remaining kynurenine ﬂuorescence originates from oligomers
that consist of unlabeled daptomycin only.
5. Oligomers are stable on the time scale of the experiment.
Let d be the fraction of native daptomycin in a mixture with NBD-
daptomycin (whose fraction is 1−d). After this mixture has under-
gone oligomerization according to conditions 1 and 3, the fraction
of oligomers that contain only native daptomycin subunits but no
NBD-daptomycin will be dn. Then, the fraction D of all native dapto-
mycin molecules from the original mixture that were incorporated
into these donor-only oligomers will be given by
D ¼ d
n
d
¼ dn−1 ð2Þ
According to assumption 4, only the oligomers represented by D
will emit observable kynurenine ﬂuorescence. Therefore, the cor-
rected relative kynurenine ﬂuorescence Fr of a given amount of dapto-
mycin that was mixed with NBD-daptomycin before oligomerization,
as deﬁned in Eq. (1), equals D. Substituting Fr for D in Eq. (2) and solv-
ing or n yields
n ¼ 1þ logd Frð Þ ¼ 1þ
ln Frð Þ
ln dð Þ ð3Þ
Therefore, we can obtain the subunit stoichiometry of the oligo-
mer by comparing the kynurenine ﬂuorescence of mixed oligomers
to that of pure native daptomycin oligomers.
In the following, we will ﬁrst present some experiments that test
the assumptions underlying the experimental approach, followed by
the experiments to measure the oligomer subunit stoichiometry.
3.2. Kinetics and linear range of the ﬂuorescence signal
Interaction of daptomycin with membranes causes a steep in-
crease in the ﬂuorescence emission of its single kynurenine residue
[10]. Fig. 1A shows the time course of kynurenine ﬂuorescence after
addition of daptomycin to PC/PG liposomes and calcium. The increase
in the ﬂuorescence signal is rapid and largely completed after 300 s.
While the ﬂuorescence increase suggests that the kynurenine residue
has entered a more hydrophobic environment, such as the apolar
interior of a lipid membrane, it may under certain conditions also
be observed in the absence of oligomerization [5] and therefore
does not prove that oligomerization has indeed occurred. Oligomeri-
zation itself can be monitored with perylene-daptomycin by way of
concomitant formation of perylene excimers [6]. The ﬂuorescence of
perylene-daptomycin at 560 nm is predominantly due to excimers
[6]. Fig. 1B shows that, as with the kynurenine ﬂuorescence, the per-
ylene excimer ﬂuorescence develops and stabilizes very rapidly after
the addition of perylene-daptomycin to liposomes and calcium.
Therefore, oligomerization proceeds rapidly and reaches completion
on the time scale of the experiment.
Fig. 1C shows that the kynurenine emission signal is linear across
the range of concentrations and under the measurement conditions
of the experiment. Thus, the kynurenine emission can be used to
measure the amount of ﬂuorescence-emitting oligomers.
3.3. Kynurenine ﬂuorescence of daptomycin in the presence of
NBD-daptomycin
When daptomycin and NBD-daptomycin are mixed and then
added to membranes, the kynurenine ﬂuorescence of the unlabeled
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Fig. 1. Time course and linear range of daptomycin ﬂuorescence responses to interaction
with liposomes. A: Time course of kynurenine ﬂuorescence of 10 μM native daptomycin
upon addition of PC/PG liposomes (250 μM total lipid) and calcium (6 mM) at time=0.
The small initial lag is caused by the shutter of the instrument. B: Time course of perylene
ﬂuorescence (λex=430 nm, λem=560 nm) of 2.5 μM perylene–daptomycin to lipo-
somes and calcium as before. The emission at 560 nm is mostly caused by excimers [6],
indicating that oligomer formation is instantaneous. C: Linear range of kynurenineﬂuores-
cence upon addition of native daptomycin to liposomes and calcium as before and incuba-
tion for 300 s.
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Fig. 2. FRET within and between daptomycin oligomers. A: Fluorescence emission spec-
tra of 2.4 μM daptomycin only, and of daptomycin (2.4 μM) plus NBD-daptomycin
(0.9 μM), pre-mixed before addition to liposomes and calcium or added sequentially
to the latter, with incubation for 3 min between the additions of the two species.
Solid lines are spectra taken 5 min after sample preparation, and dashed lines are spec-
tra acquired after an additional incubation for 10 min after the ﬁrst measurement. The
absence of an intensity decrease in the sequentially prepared sample indicates that the
donor and acceptor oligomers remain distinct and stable on the time scale of the exper-
iment. B: Kynurenine ﬂuorescence intensity of samples containing native daptomycin
and NBD-daptomycin at 2:1 molar ratio, and sequentially incubated with liposomes
and calcium, at 250 μM total lipid and the indicated ratio of lipid to total daptomycin,
relative to samples containing the same amount of native daptomycin but no NBD-
daptomycin.
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kynurenine emission in this sample suggests that most unlabeled
daptomycin has indeed been incorporated into hybrid oligomers
(assumption 3), and that its kynurenine ﬂuorescence is effectively
quenched within these hybrids (assumption 4).
Fig. 2A also shows the ﬂuorescence of a sample that was prepared
sequentially, such that unlabeled daptomycin was applied to the
membranes ﬁrst, and NBD-daptomycin was applied 3 min later.
Under these conditions, daptomycin and NBD-daptomycin should
form oligomers separately. Here, the kynurenine signal is higher. It
remains virtually unchanged after 10 min, indicating that the two
oligomer species have remained separate and have not rearranged
into hybrid oligomers; thus, individual oligomers are stable on this
time scale (assumption 5).
On the other hand, the kynurenine ﬂuorescence of the sequentially
prepared sample in Fig. 2A is below that of a sample containing
no NBD-daptomycin at all. This indicates that, in the sequentiallyprepared sample, the kynurenine ﬂuorescence of the daptomycin-
only oligomers is partially quenched by FRET to NBD-daptomycin olig-
omers in the vicinity. Raising the ratio of lipid to daptomycin reduces
but does not eliminate FRET between oligomers (Fig. 2B).
For our intended use of Eq. (3), we need to determine the FRET
that occurs within hybrid oligomers, as opposed to between them.
According to assumptions 2 and 5, we can correct for FRET between
oligomers experimentally by adding a ﬁxed quantity of unlabeled
daptomycin to the same sample after the hybrid oligomers have
been formed. The principle of this correction method is illustrated
in Fig. 3A; its details are given in the Materials and methods section.
The experiments described so far support our assumptions 2 and
5. Assumptions 3 and 4 are supported to a degree: Hybrid oligomer
formation and strong quenching by FRET are evident, but perfect
randomness of oligomerization and quantitative FRET are hard to
prove, as is the uniformity of the oligomer subunit stoichiometry
(assumption 1). For now, these latter assumptions may be taken as
working hypotheses; we will revisit them in the Discussion.
3.4. Kynurenine ﬂuorescence in hybrid oligomers formed on membranes
In the experiments shown in Fig. 4, NBD-daptomycin was com-
bined with unlabeled daptomycin at various molar ratios; the total
of both species was kept constant at 10 μM. The mixtures were
added to PC/PG membranes (250 μM total lipid) and calcium
(6 mM). The kynurenine ﬂuorescence of the ensuing oligomers was
measured and corrected for FRET between oligomers as described
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Fig. 3. Illustration of the experimental approach used to measure oligomer subunit
stoichiometry (A), and of hypothetical oligomer structures (B). A: When a mixture of
donor (D; native daptomycin) and acceptor molecules (A; NBD-daptomycin) is applied
to membranes, they randomly combine into oligomers. The fraction D1 of donor mono-
mers that become incorporated into pure donor oligomers is related to the number of
oligomer subunits according to Eq. (2). In order to determine D1 from the donor ﬂuo-
rescence, the latter must be corrected for FRET between donor-only oligomers and
acceptor-containing oligomers in the vicinity. To this end, a second sample containing
native daptomycin only is added subsequently. These molecules will all be converted to
donor-only oligomers; that is, D2=1. At the same time, they will be quenched by FRET
to acceptor-containing oligomers to the same extent as the oligomers represented by
D1. Their ﬂuorescence intensity can therefore be used to calibrate the determination
of D1 from the donor ﬂuorescence measured after the ﬁrst step.B: Hypothetical dapto-
mycin oligomer structures. It is presently unknown whether daptomycin becomes
embedded only into the outer monolayer (top) or into both monolayers (bottom). In
the latter case, it is conceivable that the distance between two subunits embedded in
different monolayers exceeds the Förster radius for FRET between kynurenine and
NBD (2.7 nm). In this case, the actual subunit stoichiometry may be up to twice the
value obtained by FRET experiments.
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Fig. 4. Determination of oligomer subunit stoichiometry by FRET. A: Kynurenine ﬂuo-
rescence intensities of 4 individual experiments, each performed at 4 different donor/
acceptor ratios. The ﬂuorescence intensities were corrected according to Eq. (1). The
curves represent theoretical values calculated according to Eq. (2). B: Subunit stoichi-
ometries calculated using Eq. (3) from the values shown in A (averages±standard
deviation).
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using Eq. (3). The calculated individual values for n vary between
5.7 and 7.5.
In sum, the results shown in Fig. 4 support the notion that dapto-
mycin forms oligomers with approximately six to seven subunits on
membranes. This interpretation must be qualiﬁed in several ways,
as discussed below.
4. Discussion
This study aimed at determining the subunit stoichiometry of the
membrane-associated daptomycin oligomer. The approach taken
here is similar to that used previously for measuring the number
of lipid II molecules that are incorporated into the transmembranepores formed by the lantibiotic nisin [11]. In both cases, random
mixing of a ﬂuorescently labeled derivative with the native species
was assumed, and the oligomer subunit stoichiometry was extracted
from the probability of mutual interaction of two ﬂuorophore mole-
cules. Both approaches also assume the interaction between two
ﬂuorophore molecules to occur with equal and complete efﬁciency,
regardless of their respective positions and distance within the
oligomer. In Ref. [11], the interaction in question was the formation
of pyrene excimers, whereas FRET was employed in the current
study. Heteromer analysis using FRET has also previously been
used to characterize the dimeric nature of membrane-associated
gramicidin [12].
Both excimer formation and FRET are sensitive to distance. In the
case of FRET, the distance dependency is given by the Förster radius,
R0, which for unlabeled daptomycin and NBD-daptomycin was previ-
ously estimated to 2.7 nm [5]. The thickness of a lipid bilayer is on
the order of 4 nm. While the ﬂuorescence changes of kynurenine in
native daptomycin [10] and of NBD in NBD-daptomycin [5] suggest
that both ﬂuorophores insert into the membrane, it is possible that
they both remain close to the membrane surface. It is currently un-
known whether a single daptomycin oligomer interacts with one or
both membrane leaﬂets. If indeed it interacts with both, subunits
located in opposite leaﬂets may be beyond the reach of mutual FRET
(see Fig. 3B). The apparent oligomer stoichiometry obtained with
the present method would then reﬂect the number of subunits in
only one of the two monolayers, and the total number of subunits
might in fact be twice as high. To resolve this question, it would be
desirable to use probes that provide a greater effective R0; however,
several other ﬂuorescent derivatives that we tested showed a signiﬁ-
cant reduction in their speciﬁc activity, which suggests that their
oligomerization may be impaired, too, and therefore that they may
not be able to randomly co-oligomerize with native daptomycin.
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Fig. 5. Numerical simulation of oligomerization with varying bimolecular rate con-
stants for the incorporation of donor and acceptor monomers into growing oligomers.
The oligomer is assumed to contain 6 subunits. The bimolecular rate constant kA, which
controls the addition of an acceptor monomer to an incomplete oligomer, was held at 1
in each case, whereas the rate constant kD, which controls the addition of a donormono-
mer to an incomplete oligomer, was varied between 0.1 and 10. The program used to
perform the calculation is listed in the supplementary ﬁle. A: For each combination of
rate constants, the fraction D of donors that are incorporated into donor-only oligomers
is plotted as a function of the fraction of donor monomers d in the initial mixture (com-
pare Eq. (2)). B: The apparent subunit stoichiometries that would be inferred from the
data shown in A according to Eqs. (2) and (3) are plotted as functions of d.
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hybrid oligomers requires correction for FRET occurring between
donor-only and acceptor-containing oligomers. In principle, it should
be possible to separate oligomers from one another by dilution, that
is, by making the ratio of daptomycin to lipid very small. However,
this approach is not feasible in practice, because the ﬂuorescence in-
tensity of kynurenine is low; its molar extinction coefﬁcient is 4000,
and its quantum yield is 0.04 [5]. Furthermore, at high lipid concen-
tration and in the presence of calcium, the PG-containing liposomes
become very turbid, which interferes with the accurate measurement
of ﬂuorescence intensities. It was therefore necessary to correct
for, rather than physically eliminate, FRET between oligomers. Our
correction procedure assumes that all daptomycin oligomers are dis-
tributed evenly in the membrane, or alternatively that the native
daptomycin applied in the second step will be distributed in the
membrane in the same manner as the mixture of the native and
NBD-daptomycin that was applied in the ﬁrst step. In this context, it
is noteworthy that the extent of FRET between oligomers (cf.
Fig. 2B) is greater than predicted for randomly distributed donors
and effectors by the pertinent formula given by Wolber and Hudson
[13] with the parameters of our system (R0=2.7 nm, surface area of
0.7 nm2 per lipid molecule). It is known that acidic phospholipids
within mixed membranes tend to cluster in the presence of calcium,
and this tendency is further promoted by proteins and peptides that
bind to them multivalently [14]. With bacterial cells, daptomycin
clusters have indeed been observed on bacterial membranes (J.
Pogliano, personal communication; manuscript in preparation). Im-
portantly, however, in those experiments, two samples of daptomy-
cin that carried two different labels and were added to the same
cells at different times were found enriched and superimposed in
the very same locations on the membrane. We assume that the
same happens on our liposome membranes.
In the previously obtained NMR structure of daptomycin in water
[15], the diameter of the peptide moiety, in a plane perpendicular to
the extended fatty acyl chain, ranges from 0.8 to 1.2 nm. Therefore,
even if we conﬁne the consideration to subunits within the same
monolayer, it is conceivable that the cumulative diameter of the olig-
omer subunits may exceed the range within which FRET can be as-
sumed to be quantitative, as was done in the present study. In this
context, however, it is interesting to note that, upon prolonged expo-
sure of daptomycin oligomers that were formed on membranes to
10 mM CHAPS, an apparent oligomer subunit stoichiometry of up to
15 was observed. This ﬁnding suggests that within the membrane—
or, as discussed above, within a membrane monolayer—it is not the
R0 that limits the extent of FRET but rather the actual number of sub-
units present. (CHAPS was also found to induce rapid destabilization
of oligomers, as evident from scrambling of donor and acceptor sub-
units, and therefore CHAPS-solubilized samples cannot be considered
a valid model of the membrane-associated state of daptomycin.)
Another caveat concerning the method employed in this study
concerns the relative rates of oligomer incorporation of the donor
and the acceptor; these rates cannot currently be measured accu-
rately. Fig. 5 shows simulated data to illustrate what happens if the
donor oligomerizes either more rapidly or more slowly than the
acceptor. While native daptomycin and NBD-daptomycin have the
same speciﬁc activity, it still seems possible that their rates of oligo-
mer incorporation may be slightly different, which may then cause
the estimated number of subunits to deviate from the true value.
Our analysis is also based on the assumption of uniform oligomer
subunit stoichiometry. While our data do not provide direct evidence
for or against this assumption, it seems to ﬁt with the previously
reported selective and speciﬁc nature of the permeability lesion
caused by daptomycin [4,16]. Less selective and possibly dose-
dependent leakage of larger marker molecules might be expected in
the case of inhomogeneous subunit stoichiometries of oligomers
and associated membrane defects.In sum, the results of our study indicate that the membrane-
associated daptomycin oligomer contains approximately six to
seven subunits. Whether this number applies to the entire oligomer
or rather to a part of it that is embedded in one of the two membrane
leaﬂets remains to be determined. In either case, the ﬁndings support
the notion that daptomycin acts through the formation of oligomers
of discrete size, rather than through detergent-like or carpet-mode
wholesale membrane disruption. This conclusion is in line with the
previously observed absence of morphological disruption of bacterial
cells exposed to daptomycin [17], as well as with the selective inhibi-
tion of membrane potential-dependent, but not of phosphotransfer-
dependent membrane transport [18].
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